Prostate Cancer Foundation

www.pcf.org

VCMatch tracks Prostate Cancer Foundation as an investor focused on Enterprise SaaS companies and United States and Global markets. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

Enterprise SaaS

Geography

United States and Global

Investment Thesis

The organization described combines a market-focused investment approach in enterprise software (B2B SaaS) with founder-led, long‑term value creation and a parallel philanthropic strategy that directs capital and resources toward translational medical research (notably precision oncology). The site highlights a core commercial thesis — “Vista invests in enterprise software (B2B SaaS) across private equity and private credit” — alongside an emphasis on using wealth and influence to expand access to care and accelerate promising science.

Is Prostate Cancer Foundation right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Prostate Cancer Foundation is most relevant for founders raising venture-backed rounds in Enterprise SaaS, especially across United States and Global.

Focus statement

Primary financial focus: investing in enterprise software (B2B SaaS) across private equity and private credit. Philanthropic focus: precision oncology, early detection and expanding access to life‑saving treatment (especially for veterans and at‑risk communities).

Value Add

Explicit combination of commercial investing and targeted philanthropy (investment in enterprise software + major gifts to precision oncology programs).
Founder background and track record: Robert F. Smith is presented as an engineer‑turned‑entrepreneur and founder/CEO of Vista, providing operational and technology expertise ('From Engineer to Entrepreneur').
Large, targeted philanthropic commitments tied to measurable programs — e.g., a $2.5M gift establishing the Robert Frederick Smith Precision Oncology Center of Excellence — that align social impact with scientific translation and access.
Use of philanthropic capital to advance practical clinical tools (Smith Polygenic Risk Test) with an explicit affordability/access goal: 'The long-term goal for the test is to keep it affordable and accessible to all men.'